Abstract：Objective To explore the effect of long-term standard inhaled drugs and home oxygen therapy on pulmonary function and quality of life in patients with chronic obstructive pulmonary disease (COPD) at stable stage, and to provide evidence for the diagnosis and treatment of patients. Methods A total of 100 patients with COPD at stable stage admitted to the Department of Respiratory Medicine, the Central Hospital of Maanshan, Anhui Province from April 2018 to April 2019 were selected as study subjects, and they were divided into observation group and control group by random number table method, with 50 patients in each group. The control group was treated with conventional therapy, while the observation group was treated with long-term standard inhaled drugs combined with home oxygen therapy for six months. The results after treatment were compared, and the changes of lung function, dyspnea score and quality of life score before and after treatment were recorded. Results The total effective rate of the observation group was significantly higher than that of the control group, with statistically significant difference (P ＜ 0.05). After treatment, forced vital capacity (FVC) and forced expiratory volume in the first second (FEV1) in both groups were increased compared with that before treatment, and the observation group was higher than the control group, ratio of forced expiratory volume in the first second to forced vital capacity (FEV1/FVC) in the observation group was increased compared with that before treatment, and the observation group was lower than the control group, the differences were statistically significant (P ＜ 0.05). After treatment, both dyspnea and quality of life scores were lower in the observation group than in the control group, and the differences were statistically significant (P ＜ 0.05). No significant adverse reactions were observed during treatment in both groups. Conclusion Long-term standardized inhaled drugs and home oxygen therapy have significant effects on COPD at stable stage, which can improve the symptoms of dyspnea, promote the recovery of pulmonary function of patients, improve the quality of life, and can be popularized in clinical use.
王晓焰 陈桂芳. 长期规范吸入药物及家庭氧疗对COPD稳定期患者肺功能及生活质量的影响[J]. 中国医药导报, 2020, 17(28): 109-112.
WANG Xiaoyan CHEN Guifang. Effect of long-term standardized inhaled drugs and home oxygen therapy on pulmonary function and quality of life in patients with COPD at stable stage. 中国医药导报, 2020, 17(28): 109-112.
[1] 户良斌，杨建全.介入有氧运动及肺康复训练联合吸入舒利迭与噻托溴铵对中重度COPD患者肺功能、运动耐力及生活质量的影响[J].中国医药导报，2017，14（17）：104-107.
[2] 王胜.长期家庭氧疗对慢性阻塞性肺疾病合并慢性呼吸衰竭患者生活质量的影响研究[J].实用医院临床杂志，2019，16（4）：158-161.
[3] 付伟，辛丽云，陈乾华.乙酰半胱氨酸溶液雾化吸入对COPD患者免疫功能及肺功能的影响[J].实用药物与临床，2019，22（6）：597-600.
[4] 戴中上，陈燕，何雪，等.长期无创正压通气对稳定期合并高碳酸血症COPD患者的治疗研究进展[J].国际呼吸杂志，2018，38（10）：791-795.
[5] 宋忠花.布地奈德福莫特罗吸入治疗对慢阻肺合并肺癌稳定期患者的疗效研究[J].河北医学，2018，24（8）：1380-1384.
[6] 黄颖，文智能.异丙托溴铵雾化吸入联合舒血宁注射液对AECOPD患者肺功能及血清MMP-9、MCP-1水平变化的影响[J].中国地方病防治杂志，2018，33（2）：235-237.
[7] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南（2007年修订版）[J].中华结核和呼吸杂志，2007，30（1）：8-17.
[8] 武伟华，张劭夫.6分钟步行试验（6MWT）、BMI及MMRC对评价COPD病情严重程度的意义[J].泰山医学院学报，2013，34（10）：740-743.
[9] 方宗君，蔡映云，蒋浩明，等.SGRQ问卷对慢性阻塞性肺病患者生命质量的评估研究[J].中国行为医学科学，1996（1）：16-17，56.
[10] 中华中医药学会内科分会肺系病专业委员会.慢性阻塞性肺疾病中医诊疗指南（201l版）[J].中医杂志，2012， 53（1）：80-84．
[11] 黄骁燕，余维巍，刘建.噻托溴铵喷雾剂对中重度稳定期慢性阻塞性肺疾病患者睡眠质量和肺功能的影响[J].中国医师进修杂志，2018，41（3）：197-200.
[12] Meshe OF，Bungay H，Claydon LS. Participants′ experiences of the benefits, barriers and facilitators of attending a community-based exercise programme for people with chronic obstructive pulmonary disease [J]. Health Soc Care Community，2020，28（3）：969-978.
[13] 刘云霞，刘志华，任翠萍，等.吸入舒利迭联合有氧运动及心肺康复训练对COPD患者心肺功能、BODE指数及运动耐量的影响[J].解放军预防医学杂志，2019，37（8）：130-131，134.
[14] Taylan M，Demir M，Kaya H，et al. Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients [J]. Clin Respir J，2017，11（3）：311-317.
[15] 陈瑞英，马小花，孙婷，等.短期强化肺康复训练对OSA-COPD共存患者呼吸、运动功能及生活质量的影响[J].中华物理医学与康复杂志，2019，41（5）：353-358.
[16] 柯华，陈维永.吸入糖皮质激素对慢性阻塞性肺疾病患者肺癌发生风险影响的系统评价[J].成都医学院学报，2018，13（4）：467-472.
[17] Ozer PA，Ogan N. Correlat?覦on of neutrophyle/lymphocyte ratio and pulmonary parameters with optic coherence tomography findings in stable chronic obstructive pulmonary disease [J]. Clin Respir J，2020，14（4）：353-363.
[18] 王伟伟，贾军辉，刘媛，等.脾多肽联合布地奈德雾化吸入对COPD急性加重期患者肺功能及动脉血气指标的影响[J].中国地方病防治杂志，2017，32（8）：919，921.
[19] 王新梅，栾念旭，靳岱红.噻托溴铵联合布地奈德福莫特罗治疗稳定期COPD疗效及对细胞免疫功能的影响[J].中国医师杂志，2019，21（8）：1254-1256.
[20] Simpson JL，Powell H，Baines KJ，et al. The effect of azithromycin in adults with stable neutrophilic COPD: a double blind randomised, placebo controlled trial [J]. PloS one，2018，9（8）：e105609-e105612.
[21] Mehring M，Donnachie E，Fexer J，et al. Disease management programs for patients with COPD in Germany: a longitudinal evaluation of routinely collected patient records [J]. Respir Care，2014，59（7）：1123-1132.
[22] 吴涛，王海娟，田桂珍，孙强.无创正压通气治疗慢性阻塞性肺疾病伴呼吸衰竭患者疗效及对炎性反应等指标的影响[J].疑难病杂志，2018，17（9）：896-899.
[23] 李改平，刘宇，徐燕杰，等.沙美特罗替卡松粉吸入剂联合无创正压通气治疗老年慢性阻塞性肺疾病合并呼吸衰竭的临床效果[J].中国医药，2017，12（8）：1153-1156.
[24] 肖芹.纳洛酮辅助无创正压通气治疗对稳定期COPD患者肺功能、动脉血气指标及心率的影响[J].成都医学院学报，2018，13（5）：554-559.
[25] Boutou AK，Kontakiotis T. Community-based pulmonary rehabilitation during acute exacerbation of chronic obstructive pulmonary disease: Pilling up the evidence [J]. Pulmonology，2020，26（2）：111-112.
[26] 沈洁，赵文凤，杨娟，等.COPD稳定期患者家庭氧疗的现状分析[J].检验医学与临床，2019，16（3）：412-415.
[27] 姜婷，傅铁军，周学群.慢性阻塞性肺疾病患者家庭氧疗干预效果分析[J].实用医院临床杂志，2017，14（2）：103-105.
[28] 李冬艳，韩保芬，闫薇.长期家庭氧疗联合肺康复训练对中重度稳定期慢性阻塞性肺疾病患者临床疗效的影响[J].中国药物与临床，2017，17（4）：550-551.
2020, Vol. 17 
京公网安备 11010502046598号